by Raynovich Rod | Aug 10, 2020 | Biopharmaceuticals, Clinical Diagnostics and Tools, Vaccines
August 15..Update -3…Momentum slows to a walk but XBI holds the $110 handle. XLV flat at $107 level, IBB down 0.86% to $133.30. Coronavirus stocks still within 10% of 52 week highs: HOLX,REGN; weak 2020 momentum: CEMI, INO. Vaccine stock leaders: NVAX, MRNA. Gov...
by Raynovich Rod | Jul 27, 2020 | Biopharmaceuticals, vaccines
Update-4 Early am trading shows weakness in COVID vaccine stocks ; Investors are focused on BIG TECH.XBI down 2% to $109 level. Vaccines require constant feeding with news flow: AZN BNTX INO MRNA NVAX all in the red. Merck (MRK) up 1% on earnings, vaacines and...
by Raynovich Rod | Jul 9, 2020 | Biopharmaceuticals, Clinical Diagnostics and Tools, Macro, Vaccines
Update-4 7/15 1:30P…Volatlity hits COVID vaccine players; BNTX, INO, NVAX down, MRNA up. Comment from CNBC contributor: “maybe vaccine news is priced in”, shows how hard it is to play daily news flow on coronavirus vaccine stocks. Strong Coronavirus...
by Raynovich Rod | Jun 23, 2020 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Clinical Diagnostics and Tools
Update-3…June 25-Re-opening Paused in FLA and TX-but stocks rally anyway. NASDAQ leads up 11% YTD. Trading remains volatile e.g. VIR. Bullish trend intact for biotech IBB up 1.11%. Vaccine stocks continue strong: BNTX INO NVAX ; MRNA lagging. Diagnostic leaders...
by Raynovich Rod | Jun 17, 2020 | Biopharmaceuticals, Clinical Diagnostics and Tools
Update-2 6/20…Strong finish for biotech on Friday with XBI up 2.83% to $108.85, up 5.64% for week; and one year high. Coronavirus strong stocks for the week: GNMK HOLX NVAX RGEN TDOC VIR . Quidel (QDEL) rests at $210 handle after rocketing from $170 level on...
by Raynovich Rod | May 31, 2020 | Biopharmaceuticals, Clinical Diagnostics and Tools
June 6… see if the Rotation Trend continues through the Week of June 8 Week Ending June 6 Performance Leaders Energy, Financials, Europe. Laggards: Staples, Healthcare. IBB off 1.95%, XBI off 1%. Stocks to watch: GILD, GSK, VIR June 5…Midday...
by Raynovich Rod | Apr 30, 2020 | Biopharmaceuticals, Clinical Diagnostics and Tools, vaccines
5/11/20 330p EDT Crazy market running up again in healthcare, life sciences and biotech; cyclicals continue to lag. XBI break-out to new highs at $104 up 4.7%. IBB up 3.94% to $133. This run reminds me of JY 2015 last big blowoff and speculative frenzy. But small...
by Raynovich Rod | Apr 26, 2020 | Biopharmaceuticals, Clinical Diagnostics and Tools
Update-2 4/29 12:15p Mid-day trading -Healthcare weak as Investors rebalance to other sectors. Gilead Sciences (GILD) up over 6% and. boosts overall market with positive remdesivir data. NAZ up 2.84%, IBB up 1.3%, IJR break-out? Technology, financials and energy show...
by Raynovich Rod | Apr 4, 2020 | Biopharmaceuticals, Clinical Diagnostics and Tools
Coronavirus (COVID-19) is an infectious disease currently spreading across the globe. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover. Others (particularly elderly people and those with underlying medical...
by Raynovich Rod | Mar 8, 2020 | Biopharmaceuticals, Clinical Diagnostics and Tools, Macro
3/30 11;30a Major news on COVID-19 diagnostics spark rally. Abbott launches 5 minute test. ABT up 7.28% ,JNJ up 6.8%, all large caps up, IBB up 2.55, XBI up 1.61%. Risk reward still looks good for biotech by year-end 2020. See IBB 2 yr chart below. ======== 3/27 After...